C18H35N3O12
Neat
485.49
Kanamycin D; 3''-deamino-3''-hydroxykanamycin A; CHEBI:73079; (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl alpha-D-glucopyranoside; (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-((6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy)-2-hydroxycyclohexyl alpha-D-glucopyranoside; RefChem:150895; (2R, 3S, 4S, 5R, 6R)-2-(aminomethyl)-6-[(1R, 2S, 3S, 4R, 6S)-4, 6-bis(azanyl)-3-[(2S, 3R, 4S, 5S, 6R)-6-(hydroxymethyl)-3, 4, 5-tris(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3, 4, 5-triol; 31077-69-7; SCHEMBL30499559; '3"-deamino-3"-hydroxykanamycin A'; C21253; Q27140286; (2R, 3S, 4S, 5R, 6R)-2-(aminomethyl)-6-[(1R, 2S, 3S, 4R, 6S)-4, 6-diamino-2-hydroxy-3-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl]oxyoxane-3, 4, 5-triol; CJX; D-Streptamine and O-6-amino-6-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku4)-O-[|A-D-glucopyranosyl-(1 inverted exclamation marku6)]-2-deoxy
(2R, 3S, 4S, 5R, 6R)-2-(aminomethyl)-6-[(1R, 2S, 3S, 4R, 6S)-4, 6-diamino-2-hydroxy-3-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl]oxyoxane-3, 4 and 5-triol
InChI=1S/C18H35N3O12/c19-2-6-8(23)10(25)12(27)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)11(26)9(24)7(3-22)31-18/h4-18,22-29H,1-3,19-21H2/t4-,5+,6+,7+,8+,9+,10-,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1